De novo cutaneous connective tissue disease temporally associated with immune checkpoint inhibitor therapy: A retrospective analysis - 15/02/21
Funding sources: None. |
|
Conflicts of interest: Nicole R. LeBoeuf is a consultant and has received honoraria from Bayer, Seattle Genetics and Sanofi outside the submitted work. The other authors have no relevant conflicts of interest to disclose. |
|
IRB approval status: The Partners Healthcare Institutional Review Board approved this study (#2015P001336). |
|
Reprints not available from the authors. |
Vol 84 - N° 3
P. 864-869 - mars 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?